Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Stem Cell Therapy International, Inc. (SCII) since 2008 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Stem Cell Therapy International, Inc.. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1360479.
Total stock buying since 2008: $907.
Total stock sales since 2008: $3,280.
Total stock option exercises since 2008: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2009 | 0 | $0 | 10,000 | $3,280 | 0 | $0 |
| 2008 | 13,962 | $907 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2009-09 | 0 | $0 | 10,000 | $3,280 | 0 | $0 |
| 2008-12 | 13,962 | $907 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-09-16 | Chau Thuy-van (Other) | Sale | 10,000 | .33 | 3,280 |
| 2008-12-11 | Stark David (President) | Buy | 13,962 | .07 | 907 |
Insider trading activities including stock purchases, stock sales, and option exercises of SCII listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Stem Cell Therapy International, Inc. (symbol SCII, CIK number 1360479) see the Securities and Exchange Commission (SEC) website.